RFK Jr. rewrites CDC panel's charter, opening door to anti-vaccine quacks
ACIP's charter now full of anti-vaccine terms and welcomes fringe groups to CDC.
As expected, anti-vaccine Health Secretary Robert F. Kennedy Jr. has significantly rewritten the charter for a federal vaccine advisory panel. The edits give him more power to appoint his like-minded allies as federal advisors, shift the panel's focus to alleged vaccine injuries and risks, and welcome fringe groups and anti-vaccine organizations to the Centers for Disease Control and Prevention. On Monday, a notice in the Federal Register indicated Kennedy renewed the charter for the CDC's Advisory Committee on Immunization Practices (ACIP), which is done every two years, with the last term having ended April 1. But instead of the usual humdrum renewal process, the notice on Monday indicated big changes were coming to the defining document of the panel, which heavily influences federal vaccine policy that, in turn, influences state requirements and insurance coverage. The new charter, published Thursday, reveals new responsibilities that redirect advisors toward topics and terms dear to anti-vaccine activists. For instance, ACIP members will now be responsible for "considering analysis of cumulative effects of vaccines and their constituent components." This wording echoes explicit goals of Kennedy's anti-vaccine allies, who aim to pin complex conditions—such as allergies, autism, and neurodevelopmental conditions—on combinations of vaccinations or common ingredients in those shots, such as aluminum adjuvants. This is a pivot from anti-vaccine activists' earlier attacks that focused on individual vaccines, such as the false, fraudulent claim that the measles vaccine is linked to autism—a claim that has been roundly debunked by dozens of high-quality studies.Read full article Comments
Quick summary
ACIP's charter now full of anti-vaccine terms and welcomes fringe groups to CDC. As expected, anti-vaccine Health Secretary Robert F.
Related tags
Companies and people
Story threads
Continue with this story
Follow the same topic through connected articles, entity pages, and active story threads.
CDC study shows COVID shot benefits; Trump official blocks release
Study found shots cut urgent care and hospitalization by about 50% in healthy adults.
After court loss, RFK Jr. gives himself more power over CDC vaccine panel
The charter renewal gives Kennedy broad authority to pick anyone for the panel.
As RFK Jr.’s anti-vaccine ways turn toxic to GOP, CDC director is hard to find
Wednesday was the deadline to nominate a new director.
"The last straw"—RFK Jr.'s anti-vaccine ally angrily quits CDC panel after spat
Robert Malone quit a vaccine panel, blaming an HHS spokesperson for "trashing" him.
Trump's MAHA pick for surgeon general flounders amid GOP doubts
She stalled over MAHA woo-woo, anti-vaccine views, and lacking medical background.
RFK may replace entire panel of CDC vaccine advisors again, ally lets slip
Robert Malone made the claim, then retracted it, as HHS denied it.
Ad slot
Article inline monetization block
A reserved partner slot for relevant tools, services, and contextual editorial integrations.
Related articles
More stories that share tags, source, or category context.
CDC study shows COVID shot benefits; Trump official blocks release
Study found shots cut urgent care and hospitalization by about 50% in healthy adults.
After court loss, RFK Jr. gives himself more power over CDC vaccine panel
The charter renewal gives Kennedy broad authority to pick anyone for the panel.
RFK Jr. wants Americans to use peptides that were banned over safety risks
The FDA is reportedly planning to allow production of 14 previously banned peptides.
More from Ars Technica
Fresh reporting and follow-up coverage from the same newsroom.
Orion helium leak no threat to Artemis II reentry, but will require redesign
After leaks on Artemis I and II, Orion's next flight to the Moon will need new valves.
AI on the couch: Anthropic gives Claude 20 hours of psychiatry
Mythos is "the most psychologically settled model we have trained to date."
Clinical trial shows gene editing works for β-Thalassaemia, too
Improved gene editing process reactivates the fetal version of a hemoglobin gene.
“Negative” views of Broadcom driving thousands of VMware migrations, rival says
Western Union exec says there were "challenges" working with Broadcom.